Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
Abstract The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years, significant progress has been made in oncological therapy, in systemic treatment, and in radiotherapy of breast cancer. Unfortunately, the imp...
Main Authors: | Agata Bikiewicz, Maciej Banach, Stephan vonHaehling, Marek Maciejewski, Agata Bielecka‐Dabrowa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13365 |
Similar Items
-
Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018-11-01) -
Cardiotoxicity Complication of Radiotherapy
by: Beta Agustia Wisman, et al.
Published: (2017-12-01) -
Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
by: Koichi Egashira, et al.
Published: (2021-06-01) -
High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT
by: Josefin Ansund, et al.
Published: (2021-02-01) -
Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
by: Caroline J. Zeiss, et al.
Published: (2019-08-01)